Shared Decision-Making Facilitates Inhaler Choice in Patients with Newly-Diagnosed Chronic Obstructive Pulmonary Disease: A Multicenter Prospective Study
Open Access
- 2 September 2022
- journal article
- research article
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 17, 2067-2078
Abstract
Purpose: Inadequate inhaler technique and nonadherence to therapy are associated with poorer clinical outcomes in chronic obstructive pulmonary disease (COPD). Shared decision-making (SDM), based on clinical evidence, patient goals and preferences, improves quality of care. This study aims to investigate the initial patients’ choices of inhaler devices in patients with newly-diagnosed COPD after an SDM process. Patients and Methods: We conducted a prospective, observational, multi-center study in four hospitals in Taiwan from December 2019 to July 2021. All treatment-naïve patients with newly-diagnosed COPD who were able to use three different inhalers of dual bronchodilators (Respimat®, Ellipta®, and Breezhaler®) in the outpatient setting were enrolled. After an SDM process, every patient was prescribed with one inhaler chosen by him- or herself. Errors of using inhalers were recorded after prescription of the inhaler, and at the follow-up visit a month later. The patients’ adherence, satisfaction score, and willingness to keep the initially chosen inhaler were investigated. Results: In 109 enrolled patients, 43, 45, and 21 patients chose Respimat®, Ellipta®, and Breezhaler®, respectively. Patients chose different inhalers had similar rates of critical error on both visits, while the rates greatly decrease on the follow-up visit, no matter which inhaler devices they chose initially. The majority of patients had good adherence (use as the prescription daily, n = 79, 82%), satisfaction (satisfaction score ≥ 4, n = 70, 73%), and strong willingness to keep the initial inhaler (n = 89, 93%) on the follow-up visit regardless of disease severity and their comorbidities. Conclusion: SDM might facilitate inhaler choosing, reduce inhaler errors (versus baseline) with good adherence, satisfaction and strong willingness to keep the initial inhaler in patients with newly-diagnosed COPD.Keywords
This publication has 33 references indexed in Scilit:
- Inhaled Drug Delivery in the Hands of the PatientJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2014
- The Importance of Continuity in Inhaler Device Choice for Asthma and Chronic Obstructive Pulmonary DiseaseRespiration, 2014
- Inhaler devices in asthma and COPD – An assessment of inhaler technique and patient preferencesRespiratory Medicine, 2014
- New Inhaler Devices - The Good, the Bad and the UglyRespiration, 2014
- The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an updateTranslational Respiratory Medicine, 2014
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Inhaler competence in asthma: Common errors, barriers to use and recommended solutionsRespiratory Medicine, 2013
- Shared Decision Making: A Model for Clinical PracticeJournal of General Internal Medicine, 2012
- Shared Treatment Decision Making Improves Adherence and Outcomes in Poorly Controlled AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat® Soft Mist™ InhalerInternational Journal of Chronic Obstructive Pulmonary Disease, 2009